0.5781

4.12% 0.0229

Cue Biopharma Inc (CUE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.5552

Offen:

$0.57

24-Stunden-Volumen:

96,231

Relative Volume:

0.36

Marktkapitalisierung:

$45.67M

Einnahmen:

$9.53M

Nettoeinkommen (Verlust:

$-44.61M

KGV:

-0.6353

EPS:

-0.91

Netto-Cashflow:

$-38.32M

1W Leistung:

-8.24%

1M Leistung:

-21.16%

6M Leistung:

-8.25%

1J Leistung:

-44.94%

1-Tages-Spanne:

$0.561

$0.58

1-Wochen-Bereich:

$0.5537

$0.6373

52-Wochen-Spanne:

$0.54

$1.75

Cue Biopharma Inc Stock (CUE) Company Profile

Firmenname

Cue Biopharma Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (632)

Telefon

617-949-2680

Adresse

40 GUEST STREET, BOSTON, MA

Mitarbeiter

Twitter

@cuebiopharma

Nächster Verdiensttermin

2025-03-31

Neueste SEC-Einreichungen

CUE's Discussions on Twitter

Vergleichen Sie CUE mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CUE Cue Biopharma Inc	0.58	43.54M	9.53M	-44.61M	-38.32M	-0.91
VRTX Vertex Pharmaceuticals Inc	458.83	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	728.89	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	462.33	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	904.45	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.85	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-03-13	Eingeleitet	Jefferies	Buy
2023-06-26	Fortgesetzt	Oppenheimer	Outperform
2022-11-21	Eingeleitet	Piper Sandler	Overweight
2022-01-13	Eingeleitet	H.C. Wainwright	Buy
2022-01-03	Eingeleitet	Craig Hallum	Buy
2020-11-24	Eingeleitet	Berenberg	Buy
2020-04-09	Eingeleitet	Stifel	Buy
2020-01-28	Eingeleitet	BTIG Research	Buy
2020-01-22	Eingeleitet	JMP Securities	Mkt Outperform

Alle ansehen

Cue Biopharma Inc Aktie (CUE) Neueste Nachrichten

Dec 04, 2025

Will Cue Biopharma Inc. stock continue upward momentum2025 Price Momentum & Fast Gain Stock Trading Tips - Newser

Dec 04, 2025

Is Cue Biopharma Inc. stock a safe investment in uncertain marketsDip Buying & Stepwise Trade Signal Implementation - Newser

Dec 04, 2025

How Cue Biopharma Inc. stock reacts to inflationary pressuresTrade Signal Summary & Real-Time Volume Triggers - Newser

Dec 04, 2025

Is Cue Biopharma Inc. (1UC) stock dividend growth reliableSwing Trade & Community Consensus Picks - Newser

Dec 04, 2025

Dec 03, 2025

Is Cue Biopharma Inc. (1UC) stock testing key supportStop Loss & Long-Term Safe Investment Ideas - Newser

Dec 03, 2025

Dec 02, 2025

What Wall Street predicts for Cue Biopharma Inc. stock price2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser

Dec 02, 2025

Will Cue Biopharma Inc. (1UC) stock benefit from infrastructure billQuarterly Earnings Report & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025

How Cue Biopharma Inc. (1UC) stock moves in volatile trading sessionsOil Prices & High Conviction Buy Zone Alerts - Newser

Dec 02, 2025

Nov 30, 2025

Can Cue Biopharma Inc. stock rebound after recent weakness2025 Volume Leaders & Technical Buy Zone Confirmation - BỘ NỘI VỤ

Nov 30, 2025

Nov 27, 2025

Is Cue Biopharma Inc (CUE) positioned for future growth? - Setenews

Nov 27, 2025

Nov 26, 2025

Will Cue Biopharma Inc. stock benefit from AI adoptionMarket Risk Summary & Community Supported Trade Ideas - moha.gov.vn

Nov 26, 2025

Nov 25, 2025

[Form 4] Cue Biopharma, Inc. Insider Trading Activity - Stock Titan

Nov 25, 2025

Nov 24, 2025

Cue Biopharma Releases Updated Corporate Presentation - TipRanks

Nov 24, 2025

[8-K] Cue Biopharma, Inc. Reports Material Event | CUE SEC FilingForm 8-K - Stock Titan

Nov 24, 2025

Nov 23, 2025